Good, W. V. (2023). Child Development Informs Pediatric Eye Disease: Marshall Parks Lecture 2023. Retrieved from https://www.ski.org/news/dr-william-good-delivers-marshall-m-parks-lecture-aao-2023
William Good
Jameson, N. ., Good, W. V., & Hoyt, C. S. (1992). Fat adherence simulating inferior oblique palsy following blepharoplasty. Archives of Ophthalmology, 110(10), 1369. 10.1001/archopht.1992.01080220031011 (Original work published 1992)
Good, W. V. (1997). Childhood hemianopia: the bigger picture. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 1(4), 189. 10.1016/s1091-8531(97)90034-3 (Original work published 1997)
Fielder, A. ., Quinn, G. E., Chan, R. P., Holmström, G. E., Chiang, M. F., Classification Committee, I. 3 ., & Good, W. V. (2022). Retinopathy of prematurity classification updates: possible implications for treatment. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 26(3), 109-112. 10.1016/j.jaapos.2022.03.003 (Original work published 2022)
Wallace, D. K., Bremer, D. L., Good, W. V., Fellows, R. R., Summers, G. ., Tung, B. ., & Hardy, R. J. (2012). Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity. Archives of Ophthalmology, 130(12), 1512-6. 10.1001/archophthalmol.2012.2118 (Original work published 2012)
Freedman, S. ., Hercinovic, A. ., Wallace, D. K., Kraker, R. ., Li, Z. ., Bhatt, A. ., … Good, W. V. (2022). Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology, 129(10), 1120-1128. 10.1016/j.ophtha.2022.05.019 (Original work published 2022)
Brodsky, M. C., & Good, W. V. (2021). Vision testing in cortical visual impairment: ocular motor confounders. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 25(6), 322-323. 10.1016/j.jaapos.2021.06.007 (Original work published 2021)
Paradis, H. ., Werdyani, S. ., Zhai, G. ., Gendron, R. L., Tabrizchi, R. ., McGovern, M. ., … Good, W. V. (2024). Genetic variants of the beta-adrenergic receptor pathways as both risk and protective factors for retinopathy of prematurity. American Journal of Ophthalmology. 10.1016/j.ajo.2023.12.017 (Original work published 2024)
Wallace, D. K., Hercinovic, A. ., Freedman, S. ., Crouch, E. ., Bhatt, A. ., Hartnett, E. ., … Investigator Group, P. E. D. . (2023). Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 27(1), 10.e1-10.e8. 10.1016/j.jaapos.2022.11.020 (Original work published 2023)
Loveridge-Easther, C. ., & Good, W. V. (2022). Ocular neovascularization following hypoxic ischemic encephalopathy. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 26(4), 216-218. 10.1016/j.jaapos.2022.04.004 (Original work published 2022)